Abstract

You have accessJournal of UrologyAdrenal1 Apr 2017MP37-08 A NEW INSIGHT FOR THE TREATMENT OF PRIMARY MACRONODULAR ADRENAL HYPERPLASIA: ADRENAL SPARING SURGERY EARLY OUTCOMES Fabio Tanno, Victor Srougi, Vania Brondani, Madson Almeida, Berenice Mendonca, Miguel Srougi, Jose Chambo, and Maria Fragoso Fabio TannoFabio Tanno More articles by this author , Victor SrougiVictor Srougi More articles by this author , Vania BrondaniVania Brondani More articles by this author , Madson AlmeidaMadson Almeida More articles by this author , Berenice MendoncaBerenice Mendonca More articles by this author , Miguel SrougiMiguel Srougi More articles by this author , Jose ChamboJose Chambo More articles by this author , and Maria FragosoMaria Fragoso More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.1140AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Partial Adrenalectomy (PA) has dramatically changed the treatment of patients affected by pathologies that affect both adrenal glands. Currently, evidences regarding the use of PA to treat primary macronodular adrenal hyperplasia(PMAH) are limited, including a small number of cases described as part of cohorts related to a variety of adrenal gland tumors. To date, the outcomes of this surgical treatment on hypercortisolism control is not known. In order to overcome the hormonal replacement caveats while minimizing the risks of hypercortisolism relapse, we performed a series of simultaneous total adrenalectomy of largest adrenal gland and contra-lateral partial adrenalectomy(adrenal sparing surgery) in patients with PMAH. METHODS Ten patients diagnosed with PMAH were treated surgically with adrenal sparing surgery. Primary endpoint was hypercortisolism remission, considered when patients had physiologic cortisol levels (5-25 μg/L) without hormonal reposition. Adrenal insufficiency and latent adrenal insufficiency were defined when oral hydrocortisone reposition was needed, with the dose of > 0,2 mg/kg/day and = 0,2 mg/kg/day, respectively.Secondary endpoints were clinical and metabolic parameters improvement. Body mass index (BMI), blood pressure, cholesterol, lipid and glucose levels, were measured before and 12 months after the procedure. Medications to control comorbidities were also assessed and compared. RESULTS There were no intra-operative complications and average operation time was 189 ± 34 minutes. Median hospitalization period was 7,5 days and one patient needed surgical hematoma drainage. With a median follow-up of 24 months (range: 13 to 63 months), 40% of the cohort had complete hypercortisolism remission, 20% persisted with latent adrenal insufficiency and 40% with adrenal insufficiency. Hypercortisolism recurrence was not observed. Median systolic/diastolic blood pressures were 155/95 before and 123/80 after the procedure (p < 0,001). Median number of medications to control blood hypertension diminished from 3 to 1(p < 0,001). There was no significant change in cholesterol, lipid and glucose blood levels as well as the number of diabetes and lipid lowering medications. Median BMI decreased from 31,7 ± 7,8 to 28,4 ± 4,7(p = 0.05). CONCLUSIONS An early assessment revealed that adrenal sparing surgery is a feasible procedure to treat patients affected by PMAH, providing hypercortisolism remission and potentially avoiding the drawbacks of lifetime corticosteroids replacement. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e477-e478 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Fabio Tanno More articles by this author Victor Srougi More articles by this author Vania Brondani More articles by this author Madson Almeida More articles by this author Berenice Mendonca More articles by this author Miguel Srougi More articles by this author Jose Chambo More articles by this author Maria Fragoso More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.